Want to join the conversation?
$APPY said it has acquired Boulder, CO-based BiOptix Diagnostics. BiOptix has developed a proprietary Enhanced Surface Plasmon Resonance technology for detection of molecular interactions. $APPY acquired as of Sept. 12 about 98% of voting shares of BiOptix for about 14% of $APPY post-deal outstanding shares. Terms of acquisition were not disclosed.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)